Explore ViiV Healthcare

I am a
  • HCP
  • person living with HIV
  • NGO or patient group
  • job seeker
  • member of the public
  • academia / entrepreneur
  • media
...looking for
  • information about VHC medicines
  • clinical data and insights on VHC medicines
  • Independent Medical Education
  • medicines in development
  • how VHC is advancing HIV treatment and care
...looking for
  • information about VHC medicines
  • information and support about living with HIV
  • how to report a side effect
  • news and stories from ViiV Healthcare
...looking for
  • funding / grants
  • ViiV Healthcare's approach to partnerships
  • how ViiV Healthcare works with NGOs
  • news and stories from ViiV Healthcare
  • connect with ViiV Healthcare's community
...looking for
  • job opportunities
  • information about ViiV Healthcare
  • ViiV Healthcare's office locations
  • news and stories from ViiV Healthcare
...looking for
  • who are ViiV Healthcare
  • corporate ethics & compliance
  • news and stories from ViiV Healthcare
...looking for
  • opportunities to partner with ViiV Healthcare
  • information on ViiV Healthcare's Innovation Unit
  • news and stories from ViiV Healthcare
...looking for
  • press releases
  • ViiV Healthcare's Leadership
  • news and stories from ViiV Healthcare

Medicines in development

Until we have a cure for HIV we must maintain investment into developing new medicines and remain vigilant over how the virus evolves resistance to treatment.

ViiV Healthcare has made significant investments in research to support a pipeline of new antiretroviral medicines; scientific progress in HIV is marked by developing new therapies that can provide benefits over existing medicines’ efficacy, side effect and resistance profiles.  As well as the three compounds that have reached Phase II or Phase III clinical trials, ViiV Healthcare is also exploring a further 16 molecules to develop potential new antiretroviral treatments. 

Medicines in clinical development

Product
Class
Phase
S/GSK1265744
Integrase inhibitor
II